Login to myMedcanLocationsCareersEmployee Programs
Memberships
Book an appointment
Manulife Vitality Program

Introducing the Galleri® multi-cancer early detection test for eligible Manulife Vitality Plus members*

Medcan is proud to partner with Manulife Vitality to offer the Galleri multi-cancer early detection test by GRAIL in Canada.

The
latest
in
proactive
cancer
screening

As a Manulife Vitality Plus member*, you benefit from a preferred rate on the Galleri multi-cancer early detection test at Medcan.

Frequently
Asked
Questions

The Galleri test is a blood test that looks for a signal that could indicate cancer. If a cancer signal is detected, the test can also identify where the cancer may have originated in the body, which can support more efficient follow-up testing. Galleri cannot diagnose cancer, but it could lead to an earlier diagnosis and can help give you better insights into your health.** If a cancer signal is detected on your Galleri test results, Medcan will guide you through follow-up testing and coordinate ongoing care with your family physician.   

It’s generally recommended to talk to your doctor or primary care provider before taking any medical test, however, if you decide to request the Galleri test, you’ll have the option to provide your doctor’s contact information. That way, in the event your test results indicate a cancer signal and diagnostic testing is recommended, your results can automatically be shared with your physician.  

Your privacy is our top priority. Your test results will not be shared with Manulife or Vitality and your results will have no impact on your current life insurance coverage or pricing, or status in the Manulife Vitality program. This offer is completely optional. If you decide not to take the test, there is also no impact on your current coverage, pricing or status in the Vitality program.  

If you make a claim in the future, your test results may be requested if they’re relevant as part of our regular process. And if you apply for new insurance, you’re required to disclose all medical test results, including Galleri.  

At this time, we are not awarding Vitality Points to members who take the Galleri test. The purpose of this offer is to make our customers aware that the Galleri test is available to them, so that they can make the most informed choices about their health.   

For clients who don’t have OHIP coverage, Medcan can administer the blood draw (onsite in Ontario), but will be unable to provide any follow-up referrals or diagnostic testing. Medcan physicians will offer to connect with the Manulife Vitality member’s primary care provider to initiate any next steps, but all follow-up care will be the responsibility of the member and their own care team.  

*Discounted access to the GRAIL Galleri® multi-cancer early detection blood test through Medcan is available to Manulife Vitality Plus™ members who meet specific eligibility criteria. To qualify, individuals must be 50 years of age or older, must not have received cancer treatment within the past three (3) years, and have coverage under the following products:

- Family Term with Vitality Plus™ policy with a total coverage amount of $1,000,000 or greater, excluding rider coverages.

- Family Term with Vitality ™ policy with a total coverage amount of $1,000,000 or greater, excluding rider coverages.

- Manulife UL with Vitality Plus™ policy with a total coverage amount of $1,000,000 or greater, including coverages from a Term Insurance Rider, but excluding other riders.

- Manulife Par with Vitality Plus™ policy with a total coverage amount of $1,000,000 or greater, including coverages from Term Insurance Rider, but excluding other riders.

Manulife Vitality Go™, Flexcare® and FollowMe™ Health & Dental products are not eligible. Eligibility for rewards may change over time and are not guaranteed over the full life of the insurance policy.

**The Galleri® multi-cancer early detection blood test does not detect a signal for all cancers. Not all cancers can be detected in the blood. False positive and false negative results do occur. 1 in 100 can expect to receive a CSD result, and approximately 60% of these individuals will receive a confirmed cancer diagnosis. The overall sensitivity in study participants with head and neck cancer was 85.7% (63.2% for stage I, 82.4% stage II, 84.2% stage III, 96.0% stage IV).

The Galleri® multi-cancer early detection blood test is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri® test is not a genetic risk assessment and does not predict future genetic risk for cancer. The Galleri® test does not detect a signal for all cancers, and not all cancers can be detected in the blood. False positive and false/negative results do occur. Galleri® should be used in addition to healthcare provider recommended screening tests.

Important Safety Information: The Galleri® test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri® test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.

Lab / Test information: GRAIL, Inc.’s clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri® test was developed, and its performance characteristics were determined by GRAIL. The Galleri® test has not been cleared or approved by the Food and Drug Administration. This test is not Health Canada or FDA approved and has not been endorsed by any professional medical societies at this time. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri® test is intended for clinical purposes.

Insurance products are issued by The Manufacturers Life Insurance Company. The Vitality Group Inc., in association with The Manufacturers Life Insurance Company, provides the ManulifeVitality program. The Manulife Vitality program is available with select policies. Manulife, Stylized M Design, and Manulife & Stylized M Design are trademarks of The Manufacturers Life Insurance Company and are used by it, and by its affiliates under license.

Galleri is a registered trademark of GRAIL, Inc.